BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9160033)

  • 1. Oleanolic acid controls allergic and inflammatory responses in experimental allergic conjunctivitis.
    Córdova C; Gutiérrez B; Martínez-García C; Martín R; Gallego-Muñoz P; Hernández M; Nieto ML
    PLoS One; 2014; 9(4):e91282. PubMed ID: 24699261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ketotifen on inflammatory markers in allergic conjunctivitis: an open, uncontrolled study.
    Martín AP; Urrets-Zavalia J; Berra A; Mariani AL; Gallino N; Gomez Demel E; Gagliardi J; Baena-Cagnani CE; Urrets-Zavalia E; Serra HM
    BMC Ophthalmol; 2003 Jan; 3():2. PubMed ID: 12515585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular changes in tears associated with keratoconjunctival responses induced by nasal allergy.
    Pelikan Z
    Eye (Lond); 2014 Apr; 28(4):430-8. PubMed ID: 24434662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptase and Exogenous Trypsin: Mechanisms and Ophthalmic Applications.
    Ma C; Li H; Lu S; Li X; Wang S; Wang W
    J Inflamm Res; 2023; 16():927-939. PubMed ID: 36891173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms.
    Sacchetti M; Plateroti R; Bruscolini A; Giustolisi R; Marenco M
    Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2.
    Li Q; Wang Z; Zheng Q; Liu S
    Comput Struct Biotechnol J; 2020; 18():2200-2208. PubMed ID: 32868983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of vernal keratoconjunctivitis in children in Saudi Arabia.
    AlHarkan DH
    Oman J Ophthalmol; 2020; 13(1):3-12. PubMed ID: 32174733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
    Rodriguez-Garcia A; Macias-Rodriguez Y; Gonzalez-Gonzalez JM
    Int Ophthalmol; 2018 Jun; 38(3):1243-1249. PubMed ID: 28602013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of vernal keratoconjunctivitis.
    Leonardi A
    Ophthalmol Ther; 2013 Dec; 2(2):73-88. PubMed ID: 25135808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular allergy guidelines: a practical treatment algorithm.
    Bielory L
    Drugs; 2002; 62(11):1611-34. PubMed ID: 12109924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of ocular allergy treatment.
    Friedlaender M
    Curr Allergy Asthma Rep; 2001 Jul; 1(4):375-9. PubMed ID: 11892061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular mast cells. Characterization in normal and disease states.
    Cook EB; Stahl JL; Barney NP; Graziano FM
    Clin Rev Allergy Immunol; 2001 Apr; 20(2):243-68. PubMed ID: 11349612
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic eye disease mechanisms.
    McGill JI; Holgate ST; Church MK; Anderson DF; Bacon A
    Br J Ophthalmol; 1998 Oct; 82(10):1203-14. PubMed ID: 9924312
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S; Schiavone M; Bonini S; Magrini L; Lischetti P; Lambiase A; Bucci MG
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans.
    Leonardi A; Abelson MB
    Clin Ther; 2003 Oct; 25(10):2539-52. PubMed ID: 14667955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H; Bitiren M; Aslan OS; Ozardali I
    Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical look at ocular allergy drugs.
    Joseph Titi M
    Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lodoxamide in vernal keratoconjunctivitis.
    Lee S; Allard TR
    Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.